Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Rob R H
RR
van den Brom
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Anja B U
AB
Mäkelburg
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Carolien P
CP
Schröder
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Elisabeth G E
EG
de Vries
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands g.a.p.hospers@umcg.nl.
Geke A P
GA
Hospers
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D016208:Databases, Factual; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D005338:Fibrin Fibrinogen Degradation Products / Q000187:drug effects; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D008875:Middle Aged; D009154:Mutation; D060735:Pharmacovigilance; D010976:Platelet Count; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000235:genetics; D012008:Recurrence; D064568:S100 Calcium Binding Protein beta Subunit / Q000097:blood; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D047368:Tumor Burden / Q000187:drug effects; D000077484:Vemurafenib
D000970:Antineoplastic Agents; D015415:Biomarkers; D014408:Biomarkers, Tumor; D005338:Fibrin Fibrinogen Degradation Products; D007211:Indoles; D064568:S100 Calcium Binding Protein beta Subunit; D013449:Sulfonamides; C036309:fibrin fragment D; D000077484:Vemurafenib; D005340:Fibrinogen; D007770:L-Lactate Dehydrogenase; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf